» Articles » PMID: 10490623

Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- and Heterodimers

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1999 Sep 22
PMID 10490623
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

The four members of the ErbB family of receptor tyrosine kinases are involved in a complex array of combinatorial interactions involving homo- and heterodimers. Since most cell types express more than one member of the ErbB family, it is difficult to distinguish the biological activities of different homo- and heterodimers. Here we describe a method for inducing homo- or heterodimerization of ErbB receptors by using synthetic ligands without interference from the endogenous receptors. ErbB receptor chimeras containing synthetic ligand binding domains (FK506-binding protein [FKBP] or FKBP-rapamycin-binding domain [FRB]) were homodimerized with the bivalent FKBP ligand AP1510 and heterodimerized with the bifunctional FKBP-FRB ligand rapamycin. AP1510 treatment induced tyrosine phosphorylation of ErbB1 and ErbB2 homodimers and recruitment of Src homology 2 domain-containing proteins (Shc and Grb2). In addition, ErbB1 and ErbB2 homodimers activated downstream signaling pathways leading to Erk2 and Akt phosphorylation. However, only ErbB1 homodimers were internalized upon AP1510 stimulation, and only ErbB1 homodimers were able to associate with and induce phosphorylation of c-Cbl. Cells expressing AP1510-induced ErbB1 homodimers were able to associate with and induce phosphorylation of c-Cbl. Cells expressing AP1510-induced ErbB1 homodimers were able to form foci; however, cells expressing ErbB2 homodimers displayed a five- to sevenfold higher focus-forming ability. Using rapamycin-inducible heterodimerization we show that c-Cbl is unable to associate with ErbB1 in a ErbB1-ErbB2 heterodimer most likely because ErbB2 is unable to phosphorylate the c-Cbl binding site on ErbB1. Thus, we demonstrate that ErbB1 and ErbB2 homodimers differ in their abilities to transform fibroblasts and provide evidence for differential signaling by ErbB homodimers and heterodimers. These observations also validate the use of synthetic ligands to study the signaling and biological specificity of selected ErbB dimers in any cell type.

Citing Articles

Multi-kinesin clusters impart mechanical stress that reveals mechanisms of microtubule breakage in cells.

Geng Q, Bonilla A, Sandwith S, Verhey K bioRxiv. 2025; .

PMID: 39974990 PMC: 11838454. DOI: 10.1101/2025.01.31.635950.


Epidermal Growth Factor Downregulates Carbon Anhydrase III (CAIII) in Colon Cancer.

Okuyan D Curr Issues Mol Biol. 2024; 46(11):12994-13002.

PMID: 39590368 PMC: 11593170. DOI: 10.3390/cimb46110774.


Gene Fusions-What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications.

Kucharczyk T, Nicos M, Kucharczyk M, Kalinka E Cancers (Basel). 2024; 16(15).

PMID: 39123493 PMC: 11311641. DOI: 10.3390/cancers16152766.


Designer Small-Molecule Control System Based on Minocycline-Induced Disruption of Protein-Protein Interaction.

Jha R, Kinna A, Hotblack A, Bughda R, Bulek A, Gannon I ACS Chem Biol. 2024; 19(2):308-324.

PMID: 38243811 PMC: 10877577. DOI: 10.1021/acschembio.3c00521.


Visualization of accessible cholesterol using a GRAM domain-based biosensor.

Koh D, Naito T, Na M, Yeap Y, Rozario P, Zhong F Nat Commun. 2023; 14(1):6773.

PMID: 37880244 PMC: 10600248. DOI: 10.1038/s41467-023-42498-7.


References
1.
Levkowitz G, Klapper L, Tzahar E, Freywald A, Sela M, Yarden Y . Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene. 1996; 12(5):1117-25. View

2.
Ho S, Biggar S, Spencer D, Schreiber S, Crabtree G . Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature. 1996; 382(6594):822-6. DOI: 10.1038/382822a0. View

3.
Rivera V, Clackson T, Natesan S, Pollock R, Amara J, Keenan T . A humanized system for pharmacologic control of gene expression. Nat Med. 1996; 2(9):1028-32. DOI: 10.1038/nm0996-1028. View

4.
Siegel P, Muller W . Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation. Proc Natl Acad Sci U S A. 1996; 93(17):8878-83. PMC: 38562. DOI: 10.1073/pnas.93.17.8878. View

5.
Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S . A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol. 1996; 16(10):5276-87. PMC: 231527. DOI: 10.1128/MCB.16.10.5276. View